Drugs that contain Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride
1. Allegra-d 12 Hour Allergy And Congestion patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US6399632 (Pediatric) | CHATTEM SANOFI | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov, 2012
(11 years ago) | |
|
US6187791 (Pediatric) | CHATTEM SANOFI | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov, 2012
(11 years ago) | |
| US5578610 | CHATTEM SANOFI | Piperidine derivatives |
Nov, 2013
(10 years ago) | |
| US7135571 | CHATTEM SANOFI | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May, 2014
(9 years ago) | |
| US7138524 | CHATTEM SANOFI | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May, 2014
(9 years ago) | |
|
US5578610 (Pediatric) | CHATTEM SANOFI | Piperidine derivatives |
May, 2014
(9 years ago) | |
|
US7135571 (Pediatric) | CHATTEM SANOFI | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov, 2014
(9 years ago) | |
|
US7138524 (Pediatric) | CHATTEM SANOFI | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov, 2014
(9 years ago) | |
| US5855912 | CHATTEM SANOFI | Pharmaceutical compositions for piperidinalkanol compounds |
Feb, 2015
(9 years ago) | |
| US6113942 | CHATTEM SANOFI | Pharmaceutical composition for piperidinoalkanol compounds |
Feb, 2015
(9 years ago) | |
|
US6113942 (Pediatric) | CHATTEM SANOFI | Pharmaceutical composition for piperidinoalkanol compounds |
Aug, 2015
(8 years ago) | |
|
US5855912 (Pediatric) | CHATTEM SANOFI | Pharmaceutical compositions for piperidinalkanol compounds |
Aug, 2015
(8 years ago) | |
| US6037353 | CHATTEM SANOFI | Method of providing an antihistaminic effect in a hepatically impaired patient |
Mar, 2017
(7 years ago) | |
|
US6037353 (Pediatric) | CHATTEM SANOFI | Method of providing an antihistaminic effect in a hepatically impaired patient |
Sep, 2017
(6 years ago) | |
| US6039974 | CHATTEM SANOFI | Pharmaceutical composition for combination of piperidinoalkanol-decongestant |
Jul, 2018
(5 years ago) | |
Market Authorisation Date: 24 January, 2011
Treatment: Method of using fexofenadine hcl in treating allergic rhinitis; Treatment of allergic rhinitis; Relief of symptoms associated with respiratory allergies, swelling of the nasal passages and sinus conge...
Dosage: TABLET, EXTENDED RELEASE;ORAL
ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION family patents
2. Allegra-d 24 Hour Allergy And Congestion patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US6399632 (Pediatric) | CHATTEM SANOFI | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov, 2012
(11 years ago) | |
|
US6187791 (Pediatric) | CHATTEM SANOFI | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov, 2012
(11 years ago) | |
| US5578610 | CHATTEM SANOFI | Piperidine derivatives |
Nov, 2013
(10 years ago) | |
| US7138524 | CHATTEM SANOFI | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May, 2014
(9 years ago) | |
|
US5578610 (Pediatric) | CHATTEM SANOFI | Piperidine derivatives |
May, 2014
(9 years ago) | |
|
US7138524 (Pediatric) | CHATTEM SANOFI | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov, 2014
(9 years ago) | |
| US6037353 | CHATTEM SANOFI | Method of providing an antihistaminic effect in a hepatically impaired patient |
Mar, 2017
(7 years ago) | |
|
US6037353 (Pediatric) | CHATTEM SANOFI | Method of providing an antihistaminic effect in a hepatically impaired patient |
Sep, 2017
(6 years ago) | |
| USRE39069 | CHATTEM SANOFI | Multi-layered osmotic device |
May, 2018
(5 years ago) | |
| US6613357 | CHATTEM SANOFI | Osmotic device containing pseudoephedrine and an H1 antagonist |
Dec, 2020
(3 years ago) | |
Market Authorisation Date: 24 January, 2011
Treatment: Relief of symptoms associated with respiratory allergies, swelling of the nasal passages and sinus congestion and pressure in adults and children 12 years of age and older
Dosage: TABLET, EXTENDED RELEASE;ORAL
ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION family patents